Serving Rockville & nearby areas • Most major insurances accepted
When traditional treatments haven’t worked, IM Ketamine may offer a new path forward. Our medically supervised approach focuses on safety, comfort, and personalized care—helping patients experience meaningful symptom relief.
Bright Horizons Psychiatry IM Ketamine is administered in a controlled clinical setting under close psychiatric supervision, with monitoring before, during, and after each session to ensure safety and comfort.
Ketamine has been widely studied for its rapid effects on mood and symptoms related to Depression. Treatment plans are personalized based on your clinical needs.
Many patients report noticeable symptom relief within hours or days rather than weeks, making IM Ketamine an option when traditional medications haven’t worked.
Each session is carefully tailored to you. Dosage, frequency, and progression are adjusted based on response, tolerability, and ongoing psychiatric evaluation.
IM Ketamine is a physician-administered treatment that works on key brain pathways involved in obsessive thoughts, compulsive behaviors, and emotional rigidity. Unlike traditional medications that can take weeks to show effects, ketamine acts on glutamate signaling, which plays a role in neural flexibility and symptom relief.
This treatment approach is personalized and guided by a comprehensive psychiatric evaluation. IM Ketamine does not require daily medication and is delivered in a controlled clinical setting with close monitoring by trained medical professionals.
During treatment, ketamine is administered via a brief intramuscular injection. Patients are observed throughout the session to ensure comfort and safety. Sessions are structured, time-limited, and tailored to individual response and tolerance.
Most patients are able to relax during treatment and typically resume normal daily activities later the same day, following a short recovery period as advised by their care team.
After years of ineffective medications, TMS at Bright Horizons transformed my outlook. With compassionate care and painless treatments, I feel lighter, think differently, and highly recommend this!
I had been struggling with depression since childhood, but Bright Horizons Psychiatry exceeded my expectations, guiding me from darkness to hope. Through compassionate care and effective treatments like Esketamine and TMS, I feel lighter, more positive, and truly on the path to recovery.
Bright Horizons exceeded my expectations, guiding me from darkness to hope. With caring staff and effective treatment, I feel lighter, more positive, and on the path to recovery from depression.
A life-changing journey with Bright Horizons—after decades of depression, I’ve found joy, connection, and hope. Grateful for the care, support, and transformation this experience has brought me.
During an IM Ketamine session, the medication is administered via a brief intramuscular injection in a comfortable clinical setting. Patients are closely monitored by trained medical staff before, during, and after treatment to ensure safety and comfort.
Sessions are structured and time-limited. Patients may experience temporary changes in perception or mood during treatment, which typically resolve within the observation period. Our care team will provide guidance on what to expect and how to prepare for each visit.
The number of IM Ketamine sessions varies depending on individual response, diagnosis, and treatment goals. Some patients notice changes within the first few sessions, while others may require a structured series over several weeks.
Treatment plans are not one-size-fits-all. Progress is regularly reviewed by the psychiatric provider, and adjustments are made based on symptom response, tolerability, and overall clinical outcomes.
When administered in a controlled medical setting, IM Ketamine is generally well tolerated. Common short-term effects may include changes in perception, dizziness, nausea, or fatigue, which typically resolve within hours.
Our care team will review potential risks and side effects in detail before treatment begins. Continuous monitoring during sessions allows providers to respond promptly to any concerns and ensures patient safety remains the top priority.
IM Ketamine treatment itself is typically not covered by insurance, as it is considered an off-label therapy for mental health conditions. However, many insurance plans do cover related services such as psychiatric consultations, evaluations, and follow-up visits.
Our team provides clear pricing information upfront and can help determine whether any portions of your care may be eligible for insurance reimbursement or out-of-network benefits.
If you’re struggling with symptoms that haven’t improved with traditional treatments, IM Ketamine may offer a new option worth exploring. Our experienced care team is here to answer your questions, review your history, and help you understand whether this treatment is right for you.
Schedule a free consultation today to learn whether IM-Ketamine is right for you and get answers from a qualified care team.
⚠️ Disclaimer on FDA Status, Off-Label Use, and Evidence Base for Ketamine in Psychiatry
Important Notice
Intramuscular (IM) ketamine treatment for depression and other mental health conditions is an off-label use. While ketamine is FDA-approved as an anesthetic, its use for psychiatric disorders—such as treatment-resistant depression, PTSD, and anxiety—is not FDA-approved.
However, off-label prescribing is both legal and common in psychiatry, especially when supported by peer-reviewed evidence and clinical expertise. Our IM ketamine protocols are informed by the growing body of psychiatric research and are delivered under close medical supervision.
Ketamine has been extensively studied in psychiatry and consistently shown to be safe and effective in controlled settings when administered appropriately:
Ahuja et al. discusses that IM ketamine is being utilized to treat psychiatric outpatients with multiple mental illnesses not limited to depression. Average depression and anxiety levels significantly improve throughout IM ketamine treatment and do not regress to baseline during patients’ maintenance treatment phase.
Hietamies et al. discusses Patients treated with ketamine exhibited significant and concordant reduction in both anxiety and depression symptoms after induction. patients experienced a significantly greater reduction in depression symptoms at eight weeks.
These and many subsequent studies have shown that when administered in controlled, medically supervised environments, ketamine is well-tolerated and safe for psychiatric use. IM ketamine, like IV, is used to harness these effects through a different route of administration.
Our clinic follows best-practice safety protocols, including medical screening, informed consent, and structured monitoring. Treatment is individualized and monitored closely for efficacy and tolerability.
References:
1-Ahuja S, Brendle M, Smart L, Moore C, Thielking P, Robison R. Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study. BMC Psychiatry. 2022 Oct 3;22(1):634. doi: 10.1186/s12888-022-04268-5. PMID: 36192794; PMCID: PMC9528178.
2-Hietamies TM, McInnes LA, Klise AJ, Worley MJ, Qian JJ, Williams LM, Heifets BD, Levine SP. The effects of ketamine on symptoms of depression and anxiety in real-world care settings: A retrospective controlled analysis. J Affect Disord. 2023 Aug 15;335:484-492. doi: 10.1016/j.jad.2023.04.141. Epub 2023 May 16. PMID: 37201900.
